BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33089366)

  • 1. Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma-not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry.
    Fuji S; Kida S; Nakata K; Morishima T; Miyashiro I; Ishikawa J
    Ann Hematol; 2021 Jan; 100(1):157-165. PubMed ID: 33089366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results Database.
    Bhatt VR; Giri S; Verma V; Manandhar S; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):373-8. PubMed ID: 27349764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.
    Kawamoto K; Miyoshi H; Yanagida E; Yoshida N; Kiyasu J; Kozai Y; Morikita T; Kato T; Suzushima H; Tamura S; Muta T; Kato K; Eto T; Seki R; Nagafuji K; Sone H; Takizawa J; Seto M; Ohshima K
    Eur J Haematol; 2017 May; 98(5):459-466. PubMed ID: 28129454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency, distribution, and immunomorphologic characteristics of peripheral T-cell lymphoma, not otherwise specified in a tertiary care center in Southern India.
    Lakshmanan A; Sikri D; Patil S; Kurian A; Annapurneswari S; Nair S
    Indian J Pathol Microbiol; 2018; 61(2):204-208. PubMed ID: 29676358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma.
    Yamasaki S; Yoshida S; Kato K; Choi I; Imamura Y; Kohno K; Henzan H; Tanimoto K; Ogawa R; Suehiro Y; Miyamoto T; Eto T; Ohshima K; Akashi K; Iwasaki H;
    Int J Hematol; 2020 Jul; 112(1):74-83. PubMed ID: 32297159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lower ALC/AMC ratio is associated with poor prognosis of peripheral T-cell lymphoma-not otherwise specified.
    Li Q; Gao S; Ma J; Liu S; Yue Y; Chen L; Li H; Wang X; Li D; Cao Z; Zhao Z; Wang X; Yu Y; Zhang Y; Wang Y
    Leuk Res; 2018 Oct; 73():5-11. PubMed ID: 30172956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous peripheral T-cell lymphoma, not otherwise specified: A single-center prognostic analysis.
    Tolkachjov SN; Weenig RH; Comfere NI
    J Am Acad Dermatol; 2016 Nov; 75(5):992-999. PubMed ID: 27498959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcomes of Patients with Adult T Cell Leukemia-Lymphoma in a Nonendemic Metropolitan Area: A Retrospective Analysis of the Population-Based Osaka Cancer Registry.
    Fuji S; Kida S; Morishima T; Nakata K; Miyashiro I; Ishikawa J
    Biol Blood Marrow Transplant; 2020 Aug; 26(8):1433-1438. PubMed ID: 32417489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma.
    Kato A; Imai Y; Aoki K; Tabata S; Matsushita A; Hashimoto H; Takahashi T; Ishikawa T
    Ann Hematol; 2014 Jul; 93(7):1185-91. PubMed ID: 24526138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral T-Cell Lymphoma, not Otherwise Specified (PTCL-NOS).
    Oluwasanjo A; Kartan S; Johnson W; Alpdogan O; Gru A; Mishra A; Haverkos BM; Gong J; Porcu P
    Cancer Treat Res; 2019; 176():83-98. PubMed ID: 30596214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic indices for peripheral T-cell lymphoma - not otherwise specified and adult T-cell leukemia/lymphoma: From past to future.
    Ishitsuka K
    J Clin Exp Hematop; 2023 Mar; 63(1):1-11. PubMed ID: 36709976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral T-cell lymphoma--not otherwise specified.
    Savage KJ; Ferreri AJ; Zinzani PL; Pileri SA
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):321-9. PubMed ID: 20702104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective study from the national hospital organization in Japan.
    Yamasaki S; Iida H; Yoshida I; Komeno T; Sawamura M; Matsumoto M; Sekiguchi N; Hishita T; Sunami K; Shimomura T; Takatsuki H; Yoshida S; Otsuka M; Kato T; Kuroda Y; Ooyama T; Suzuki Y; Ohshima K; Nagai H; Iwasaki H
    Leuk Lymphoma; 2021 Apr; 62(4):819-827. PubMed ID: 33167741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma.
    Yamasaki S; Chihara D; Kim SW; Kawata T; Mizuta S; Ago H; Chou T; Yamane T; Uchiyama H; Oyake T; Miura K; Saito B; Taji H; Nakamae H; Miyamoto T; Fukuda T; Kanda J; Atsuta Y; Suzuki R
    Int J Hematol; 2019 Feb; 109(2):175-186. PubMed ID: 30430419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival in patients with limited-stage peripheral T-cell lymphomas.
    Briski R; Feldman AL; Bailey NG; Lim MS; Ristow K; Habermann TM; Macon WR; Inwards DJ; Colgan JP; Nowakowski GS; Kaminski MS; Witzig TE; Ansell SM; Wilcox RA
    Leuk Lymphoma; 2015 Jun; 56(6):1665-70. PubMed ID: 25248884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged survival of patients with peripheral T-cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantation.
    Prochazka V; Faber E; Raida L; Vondrakova J; Kucerova L; Jarosova M; Indrak K; Papajik T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):63-6. PubMed ID: 19365529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of l-kynurenine predict clinical outcomes of patients with peripheral T-cell lymphoma, not otherwise specified.
    Shibata Y; Hara T; Matsumoto T; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Goto N; Nannya Y; Ito H; Kito Y; Miyazaki T; Takeuchi T; Saito K; Seishima M; Takami T; Moriwaki H; Shimizu M; Tsurumi H
    Hematol Oncol; 2017 Dec; 35(4):637-644. PubMed ID: 27338762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades.
    Liu W; Ji X; Song Y; Wang X; Zheng W; Lin N; Tu M; Xie Y; Ping L; Ying Z; Zhang C; Deng L; Wu M; Feng F; Leng X; Sun Y; Du T; Zhu J
    Cancer Med; 2020 Jun; 9(11):3765-3774. PubMed ID: 32281275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THE ROLE OF RADIATION THERAPY IN THE TREATMENT OF PTCL-NOS.
    Kriachok I; Aleksyk O; Tytorenko I; Bushuieva M; Moroz Y
    Probl Radiac Med Radiobiol; 2023 Dec; 28():504-512. PubMed ID: 38155144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of non-anaplastic peripheral T-cell lymphoma in pediatric patients in Japan.
    Kobayashi R; Yamato K; Tanaka F; Takashima Y; Inada H; Kikuchi A; Kumagai MA; Sunami S; Nakagawa A; Fukano R; Fujita N; Mitsui T; Tsurusawa M; Mori T;
    Pediatr Blood Cancer; 2010 Feb; 54(2):212-5. PubMed ID: 19856396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.